Table 1 Contingency table comparing conventional and refined intrinsic subtypes among 1097-case TCGA BC cohort.

From: PCA-PAM50 improves consistency between breast cancer intrinsic and clinical subtyping reclassifying a subset of luminal A tumors as luminal B

 

Refined intrinsic subtype

Basal

Her2

LA

LB

Normal

Sum

Conventional

Intrinsic

subtype

Basal

185

5

0

2

0

192

Her2

0

82

0

0

0

82

LA

0

7

452

107

0

566

LB

0

1

0

216

0

217

Normal

1

5

21

2

11

40

Sum

186

100

473

327

11

1097

  1. For the plots in Fig. 4, we used the patients that are either LA or LB in both conventional and refined subtypes (underlined).
Back to article page